Cytosorbents (CTSO) Short-term Investments (2014 - 2024)

Cytosorbents (CTSO) reported Short-term Investments of $5.0 million for Q4 2024, up 1908.03% quarter-over-quarter from $249000.0 in Q2 2016.

Cytosorbents (CTSO) Short-term Investments (2014 - 2024) Analysis & Trends

Cytosorbents has reported Short-term Investments for 4 years, with the latest figure at $5.0 million in Q4 2024.

For the quarter ending Q4 2024, Short-term Investments changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2024 stood at $5.0 million (changed N/A YoY), and the FY2024 full-year result was $5.0 million, changed N/A from the prior year.
Short-term Investments for Q4 2024 stood at $5.0 million, up from $249000.0 in the prior quarter.
The five-year high for Short-term Investments was $5.0 million in Q4 2024, with the low at $5.0 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Cytosorbents	28.80 Mn	24.00 Mn	6.13 Mn

Download Data